Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Endocrine Journal|June 22, 2025
Imbalances in adrenal hormones and their effects on bone metabolismMaki Yokomoto-Umakoshi, Hironobu Umakoshi, Yoshihiro Ogawa
Endocrine Journal|May 23, 2017
Association between the risk of falls and osteoporotic fractures in patients with type 2 diabetes mellitusMaki Yokomoto-Umakoshi, Ippei Kanazawa, Shiori Kondo, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2015
Hypercalcemic crisis due to primary hyperparathyroidism occurring concomitantly with Graves' diseaseMaki Yokomoto, Mayu Minamoto, Daisuke Utsunomiya, et al.
Bone|November 30, 2020
Investigating the causal effect of fibroblast growth factor 23 on osteoporosis and cardiometabolic disorders: A Mendelian randomization studyMaki Yokomoto-Umakoshi, Hironobu Umakoshi, Takashi Miyazawa, et al.
Biochemical and Biophysical Research Communications|December 30, 2015
Activation of AMP-activated protein kinase decreases receptor activator of NF-κB ligand expression and increases sclerostin expression by inhibiting the mevalonate pathway in osteocytic MLO-Y4 cellsMaki Yokomoto-Umakoshi, Ippei Kanazawa, Ayumu Takeno, et al.
Endocrine Journal|February 5, 2016
Simvastatin rescues homocysteine-induced apoptosis of osteocytic MLO-Y4 cells by decreasing the expressions of NADPH oxidase 1 and 2Ayumu Takeno, Ippei Kanazawa, Ken-Ichiro Tanaka, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 24, 2017
The Latest Developments of Functional Molecular Imaging in the Diagnosis of Primary AldosteronismMitsuhide Naruse, Hironobu Umakoshi, Mika Tsuiki, et al.
Bone|May 3, 2015
Activation of AMP-activated protein kinase protects against homocysteine-induced apoptosis of osteocytic MLO-Y4 cells by regulating the expressions of NADPH oxidase 1 (Nox1) and Nox2Ayumu Takeno, Ippei Kanazawa, Ken-Ichiro Tanaka, et al.
Calcified Tissue International|February 24, 2017
Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 CellsMasakazu Notsu, Ippei Kanazawa, Ayumu Takeno, et al.
Internal Medicine (Tokyo, Japan)|January 11, 2019
Seasonal Variation in Severe Glucose-lowering Drug-induced Hypoglycemia in Patients with Type 2 DiabetesMayu Minamoto-Higashioka, Ryoichi Kawamura, Hironobu Umakoshi, et al.
Pageof 4